Exponent Intrinsic Value – EXPONENT Reports Positive Financial Results for Q2 FY2023

☀️Earnings Overview

EXPONENT ($NASDAQ:EXPO) announced their financial results for the second quarter of FY2023 on June 30th, 2023. The total revenue for the quarter was USD 140.2 million, which is a 7.6% increase from the same period in the previous year. Net income, however, remained the same at USD 25.8 million when compared to the same quarter in the prior year.

Stock Price

The company’s stock opened at $95.4 and closed at $93.7, down 1.5% from the previous day’s closing price of 95.1. Despite the slight decrease in the stock price, the company’s results remain encouraging, indicating that they are on track to achieve their financial goals for the rest of the year. This increase in revenue was mainly driven by strong demand for EXPONENT’s products and services across various industries. EXPONENT’s management team was pleased with the results and expressed confidence that the company will continue to deliver strong financial performance in the coming quarters.

They attributed the success to their commitment to innovation and customer satisfaction, as well as their ability to capitalize on market opportunities. Looking forward, they expect to further improve their results and remain competitive in the global market. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Exponent. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Exponent. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Exponent. More…

Key Ratios Snapshot

Some of the financial key ratios for Exponent are shown below. More…

Analysis – Exponent Intrinsic Value

Our team at GoodWhale recently conducted an analysis of EXPONENT‘s wellbeing, and based on our proprietary Valuation Line, we have determined that the intrinsic value of EXPONENT shares is around $109.1. We have also found that the EXPONENT stock is currently trading at $93.7, which is a fair price that is undervalued by 14.1%. This means that there is an opportunity to purchase EXPONENT shares at a discount and take advantage of potential upside in the market. In addition, we believe that EXPONENT is in a strong financial position to weather market fluctuations in the near term, which makes it an attractive asset for investors with a long term outlook. More…

Peers

With over 3,000 employees in more than 85 offices around the world, Exponent has the breadth and depth of expertise to support our clients with multidisciplinary solutions to solve the most complex problems. We work with a range of clients in the oil and gas, chemical, pharmaceutical, power, manufacturing, and technology industries, as well as government agencies and nonprofit organizations.

– Zhenhai Petrochemical Engineering Co Ltd ($SHSE:603637)

Zhenhai Petrochemical Engineering Co Ltd is a Chinese company that provides engineering, procurement, and construction services to the petrochemical industry. The company has a market capitalization of 2.09 billion as of 2022 and a return on equity of 5.9%. Zhenhai Petrochemical Engineering Co Ltd is a publicly traded company listed on the Shanghai Stock Exchange.

– Sino Daan Co Ltd ($SZSE:300635)

Sino Daan Co Ltd is a company that manufactures and sells electronic products. The company has a market cap of 1.92B as of 2022 and a return on equity of 3.86%. The company’s products include mobile phones, tablets, laptops, and other electronic devices.

– Wison Engineering Services Co Ltd ($SEHK:02236)

Wison Engineering Services Co Ltd has a market cap of 1.12B as of 2022. The company provides engineering, procurement, and construction services in China. It has a Return on Equity of -2.43%.

Summary

EXPONENT‘s financial results for the second quarter of FY2023 show a healthy total revenue of USD 140.2 million, a 7.6% increase year-over-year. Net income remained consistent at USD 25.8 million. For investors, this is a positive sign that the company is continuing to grow despite the global pandemic and economic downturn. EXPONENT has demonstrated healthy fiscal performance and reliability, indicating a strong outlook for the future and making it an attractive investment option.